AstraZeneca Executive VP, Discovery Research, Jan Lundberg, An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec addresses oncology pipeline, Bristol diabetes deal.
You may also be interested in...
AstraZeneca Gives Iressa Another Go In The EU
Filing for marketing authorization in lung cancer comes three years after AstraZeneca initially withdrew its application.
AstraZeneca Gives Iressa Another Go In The EU
Filing for marketing authorization in lung cancer comes three years after AstraZeneca initially withdrew its application.
AstraZeneca Executive VP, Discovery Research, Jan Lundberg: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
AstraZeneca's chief of discovery research discusses his company's pipeline, its plans related to the acquisitions of MedImmune and CAT, and whether the Exanta compound has any developmental future with "The Pink Sheet" DAILY.